Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ANTH | ANTHRAX (BIOTHRAX) | EMERGENT BIOSOLUTIONS | 2 | 300211A | IM / RA |
Patient presented on day 7 after vaccine, having first developed symptoms on day 5 after vaccine. She was diagnosed with nonpurulent cellulitis at the vaccine site, with induration of approximately 8.5cm x 10cm. She did not have systemic symptoms, including fever. She was prescribed Keflex.
None
Migraine with aura, astigmatism bilateral
cranberry capsule, multivitamin, fluocinolone 0.01% topical, ketoconazole 2% topical, norgestimate-ethinyl estradiol
None